Literature DB >> 9134959

Sequelae of parenteral domoic acid administration in rats: comparison of effects on different metabolic markers in brain.

N M Appel1, S I Rapoport, J P O'Callaghan, J M Bell, L M Freed.   

Abstract

Parenterally administered domoic acid, a structural analog of the excitatory amino acids glutamic acid and kainic acid, has specific effects on brain histology in rats, as measured using different anatomic markers. Domoic acid-induced convulsions affects limbic structures such as hippocampus and entorhinal cortex, and different anatomic markers can detect these neurotoxic effects to varying degrees. Here we report effects of domoic acid administration on quantitative indicators of brain metabolism and gliosis. Domoic acid, 2.25 mg/kg i.p., caused stereotyped behavior and convulsions in approximately 60% of rats which received it. Six to eight days after domoic acid or vehicle administration, the animals were processed to measure regional brain incorporation of the long-chain fatty acids [1-(14)C]arachidonic acid ([14C]AA) and [9,10-(3)H]palmitic acid ([3H]PA), or regional cerebral glucose utilization (rCMRglc) using 2-[1-(14)C]deoxy-D-glucose, by quantitative autoradiography. Others rats were processed to measure brain glial fibrillary acidic protein (GFAP) by enzyme-linked immunosorbent assay. Domoic acid increased GFAP in the anterior portion of cerebral cortex, the caudate putamen and thalamus compared with vehicle. However, in rats that convulsed after domoic acid GFAP was significantly increased throughout the cerebral cortex, as well as in the hippocampus, septum, caudate putamen, and thalamus. Domoic acid, in the absence of convulsions, decreased relative [14C]AA incorporation in the claustrum and pyramidal cell layer of the hippocampus compared with vehicle-injected controls. In the presence of convulsions, relative [14C]AA incorporation was decreased in hippocampus regions CA1 and CA2. Uptake of [3H]PA into brain was unaffected. Relative rCMRglc decreased in entorhinal cortex following domoic acid administration with or without convulsions. These results suggest that acute domoic acid exposure affects discrete brain circuits by inducing convulsions, and that domoic acid-induced convulsions cause chronic effects on brain function that are reflected in altered fatty acid metabolism and gliosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9134959     DOI: 10.1016/s0006-8993(97)00042-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

1.  Repeated low level domoic acid exposure increases CA1 VGluT1 levels, but not bouton density, VGluT2 or VGAT levels in the hippocampus of adult mice.

Authors:  Caitlin E Moyer; Emma M Hiolski; David J Marcinek; Kathi A Lefebvre; Donald R Smith; Yi Zuo
Journal:  Harmful Algae       Date:  2018-09-05       Impact factor: 4.273

2.  Effect of a short-term in vitro exposure to the marine toxin domoic acid on viability, tumor necrosis factor-alpha, matrix metalloproteinase-9 and superoxide anion release by rat neonatal microglia.

Authors:  A M Mayer; M Hall; M J Fay; P Lamar; C Pearson; W C Prozialeck; V K Lehmann; P B Jacobson; A M Romanic; T Uz; H Manev
Journal:  BMC Pharmacol       Date:  2001-10-02

Review 3.  Public health risks associated with chronic, low-level domoic acid exposure: A review of the evidence.

Authors:  Rebekah Petroff; Alicia Hendrix; Sara Shum; Kimberly S Grant; Kathi A Lefebvre; Thomas M Burbacher
Journal:  Pharmacol Ther       Date:  2021-04-28       Impact factor: 12.310

Review 4.  Domoic acid toxicologic pathology: a review.

Authors:  Olga M Pulido
Journal:  Mar Drugs       Date:  2008-05-28       Impact factor: 5.118

5.  Differential effects of domoic acid and E. coli lipopolysaccharide on tumor necrosis factor-alpha, transforming growth factor-beta1 and matrix metalloproteinase-9 release by rat neonatal microglia: evaluation of the direct activation hypothesis.

Authors:  Alejandro M S Mayer; Marcio Guzman; Renee Peksa; Mary Hall; Michael J Fay; Peer B Jacobson; Anne M Romanic; Sarath P Gunasekera
Journal:  Mar Drugs       Date:  2007       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.